This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0E0NI_M.jpg
Bristol-Myers Squibb announced earnings per share of $1.63 on revenue of $10.54B. Analysts polled by Investing.com anticipated EPS of $1.49 on revenue of $10.33B.
Bristol-Myers Squibb shares are down 21% from the beginning of the year, still down 4.26% from its 52 week high of $68.34 set on January 22. They are under-performing the AEX which is down 5.31% from the start of the year.
Bristol-Myers Squibb’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
